JPS5736816A
(ja)
|
1980-08-14 |
1982-02-27 |
Toshiba Corp |
Chodendokoirunoseizohoho
|
JPS57192573A
(en)
|
1981-05-25 |
1982-11-26 |
Hochiki Co |
Fire fighting agent
|
JPS60165712A
(ja)
|
1984-02-08 |
1985-08-28 |
パイオニア株式会社 |
可変調整部品の自動調整方法
|
JPS6126111A
(ja)
|
1984-07-16 |
1986-02-05 |
Shin Meiwa Ind Co Ltd |
産業用ロボツト
|
JPS6137764A
(ja)
|
1984-07-31 |
1986-02-22 |
Suntory Ltd |
抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物
|
JPS6152021A
(ja)
|
1984-08-22 |
1986-03-14 |
Fujitsu Ltd |
スケルチ回路
|
JPH0647573B2
(ja)
*
|
1984-08-29 |
1994-06-22 |
メクト株式会社 |
2−アゼチジノン誘導体及びその製造方法
|
JPS6172439A
(ja)
|
1984-09-18 |
1986-04-14 |
Sanyo Electric Co Ltd |
デ−タ転送方式
|
EP0201741B1
(en)
|
1985-04-16 |
1991-07-31 |
Suntory Limited |
Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
|
JPH0623190B2
(ja)
|
1985-04-16 |
1994-03-30 |
サントリー株式会社 |
インヒビタ−活性を有するn−アシルピロリジン誘導体及びその製法並びに用途
|
CA1298033C
(en)
|
1985-04-16 |
1992-03-24 |
Takaharu Tanaka |
Dipeptide derivative of fatty acid
|
JPS62114957A
(ja)
|
1985-11-13 |
1987-05-26 |
Suntory Ltd |
プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジン誘導体およびその製法並びに用途
|
JPH0714878B2
(ja)
|
1985-11-14 |
1995-02-22 |
サントリー株式会社 |
ピロリジンアミドを有効成分とするプロリルエンドペプチダーゼ阻害剤
|
JPH0764834B2
(ja)
|
1985-11-29 |
1995-07-12 |
サントリー株式会社 |
プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
|
US5198458A
(en)
|
1986-02-04 |
1993-03-30 |
Suntory Limited |
Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same
|
CA1320734C
(en)
|
1986-02-04 |
1993-07-27 |
Suntory Limited |
Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
|
CA1334092C
(en)
|
1986-07-11 |
1995-01-24 |
David John Carini |
Angiotensin ii receptor blocking imidazoles
|
JPS6386485A
(ja)
|
1986-09-30 |
1988-04-16 |
Agency Of Ind Science & Technol |
トンネル型ジヨセフソン接合素子
|
US5223482A
(en)
|
1986-11-17 |
1993-06-29 |
Scios Nova Inc. |
Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
|
JPH08806B2
(ja)
|
1986-11-18 |
1996-01-10 |
サントリー株式会社 |
プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
|
DE3786229T2
(de)
|
1986-11-20 |
1993-10-07 |
Ono Pharmaceutical Co |
Prolinalderivate.
|
US5254550A
(en)
|
1986-11-20 |
1993-10-19 |
Ono Pharmaceutical Co., Ltd. |
Prolinal derivatives and pharmaceutical compositions thereof
|
JPS63162672A
(ja)
|
1986-12-25 |
1988-07-06 |
Ono Pharmaceut Co Ltd |
新規なプロリナ−ル誘導体、それらの製造方法およびそれらを含有する抗健忘症剤
|
ATE84787T1
(de)
|
1986-12-29 |
1993-02-15 |
Ono Pharmaceutical Co |
Prolin-derivate.
|
US5262431A
(en)
|
1986-12-29 |
1993-11-16 |
Ono Pharmaceutical Co., Ltd. |
Prolinal derivatives and pharmaceutical compositions thereof
|
JPH089591B2
(ja)
|
1986-12-29 |
1996-01-31 |
小野薬品工業株式会社 |
新規なプロリナール誘導体
|
DE3879522T2
(de)
|
1987-02-04 |
1993-09-02 |
Ono Pharmaceutical Co |
Prolinalderivate.
|
DE3875361T2
(de)
|
1987-02-23 |
1993-03-25 |
Ono Pharmaceutical Co |
Thiazolidin-derivate.
|
JPS6442465A
(en)
|
1987-08-07 |
1989-02-14 |
Wakunaga Pharma Co Ltd |
N-acylprolylpyrrolidine derivative, production and use thereof
|
JP2649237B2
(ja)
|
1988-03-07 |
1997-09-03 |
キッセイ薬品工業 株式会社 |
チアゾリジン誘導体
|
US4857524A
(en)
|
1987-08-08 |
1989-08-15 |
Kissei Pharmaceutical Co., Ltd. |
Thiazolidine compounds and therapeutic method
|
JP2515558B2
(ja)
|
1987-09-10 |
1996-07-10 |
株式会社ヤクルト本社 |
新規なペプチドおよびそれを有効成分とする抗健忘症剤
|
CA1339014C
(en)
|
1987-10-08 |
1997-03-25 |
Ronald E. Majocha |
Antibodies to a4 amyloid peptide
|
JPH0742309B2
(ja)
|
1987-11-30 |
1995-05-10 |
キッセイ薬品工業株式会社 |
チアゾリジン誘導体
|
JPH01250370A
(ja)
|
1987-12-23 |
1989-10-05 |
Zeria Pharmaceut Co Ltd |
新規アミノ酸イミド誘導体、製法ならびに用途
|
US5053414A
(en)
|
1988-04-08 |
1991-10-01 |
Ono Pharmaceutical Co., Ltd. |
Heterocyclic compounds
|
US5328899A
(en)
|
1988-07-15 |
1994-07-12 |
The Salk Institute For Biological Studies |
NPY peptide analogs
|
ZA896376B
(en)
|
1988-08-26 |
1990-05-30 |
Merrell Dow Pharma |
Neuropeptide y agonists
|
ZA896374B
(en)
|
1988-08-26 |
1990-05-30 |
Merrell Dow Pharma |
Neuropeptide y antagonists
|
JP2531989B2
(ja)
|
1988-09-14 |
1996-09-04 |
吉富製薬株式会社 |
ピリジン化合物
|
CA2004028C
(en)
|
1988-12-08 |
1998-09-22 |
Motoki Torizuka |
Condensed benzene derivative
|
JPH02207070A
(ja)
|
1989-02-07 |
1990-08-16 |
Zeria Pharmaceut Co Ltd |
アミノ酸イミド誘導体、それを含有する医薬及び該化合物の製造中間体
|
WO1990012005A1
(en)
|
1989-04-13 |
1990-10-18 |
Japan Tobacco Inc. |
New amino acid derivatives having prolylendopeptidase inhibitor activity
|
WO1990012870A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Monoclonal antibody to amyloid peptide
|
WO1990012871A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Cerebrovascular amyloid protein-specific monoclonal antibody sv17-6e10
|
ATE190051T1
(de)
|
1989-06-14 |
2000-03-15 |
Smithkline Beecham Corp |
Imidazoalkensäure
|
DE3939797A1
(de)
|
1989-12-01 |
1991-06-06 |
Basf Ag |
Neue vom neuropeptid y abgeleitete peptide
|
US4985560A
(en)
|
1990-01-12 |
1991-01-15 |
American Home Products Corporation |
Pyridazino(4,5-b)indolizines
|
IL97219A
(en)
|
1990-02-19 |
1995-12-08 |
Ciba Geigy Ag |
Elliptical amino compounds converted by biphenyl process for their preparation and pharmaceutical preparations containing them
|
JPH04211648A
(ja)
|
1990-07-27 |
1992-08-03 |
Nippon Kayaku Co Ltd |
ケト酸アミド誘導体
|
JPH03255080A
(ja)
|
1990-03-05 |
1991-11-13 |
Yoshitomi Pharmaceut Ind Ltd |
ベンゼン化合物
|
IE910913A1
(en)
|
1990-03-20 |
1991-09-25 |
Sanofi Sa |
N-substituted heterocyclic derivates, their preparation¹and pharmaceutical compositions containing them
|
US5073549A
(en)
|
1990-03-22 |
1991-12-17 |
Bristol-Myers Squibb Company |
BU-4164E - A and B, prolyl endopeptidase inhibitors and their methods of use
|
US4999349A
(en)
|
1990-03-22 |
1991-03-12 |
Bristol-Myers Squibb Co. |
BU-4164E - A and B, prolyl endopeptidase inhibitors
|
US5196444A
(en)
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
WO1991018891A1
(en)
|
1990-06-04 |
1991-12-12 |
Pfizer Inc. |
Aromatic pyrrolidine and thiazolidine amides
|
ATE133407T1
(de)
|
1990-06-07 |
1996-02-15 |
Zeria Pharm Co Ltd |
Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel
|
EP0468469A2
(en)
|
1990-07-27 |
1992-01-29 |
Japan Tobacco Inc. |
Proline derivatives
|
US5506256A
(en)
|
1990-07-27 |
1996-04-09 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Proline derivatives possessing prolyl endopeptidase-inhibitory activity
|
JPH05186498A
(ja)
|
1991-12-27 |
1993-07-27 |
Japan Tobacco Inc |
プロリン誘導体
|
JPH04235162A
(ja)
|
1990-08-09 |
1992-08-24 |
Zeria Pharmaceut Co Ltd |
新規コハク酸アミド誘導体およびそれを含有する医薬
|
JPH04208299A
(ja)
|
1990-11-30 |
1992-07-29 |
Ajinomoto Co Inc |
プロリルエンドペプチターゼ阻害ペプチド
|
IS1756B
(is)
|
1991-02-21 |
2000-12-28 |
Sankyo Company Limited |
Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
|
US5104880A
(en)
|
1991-05-01 |
1992-04-14 |
Mayo Foundation For Medical Education And Research |
Huperzine a analogs as acetylcholinesterase inhibitors
|
WO1992021333A2
(en)
|
1991-05-24 |
1992-12-10 |
Pharmavene, Inc. |
Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
|
WO1993000361A1
(fr)
|
1991-06-20 |
1993-01-07 |
Snow Brand Milk Products Co., Ltd. |
Nouveaux inhibiteurs de propyle d'endopeptidase sna-115 et sna-115t, leur production et souche utilisee dans leur production
|
DE4121975A1
(de)
|
1991-07-03 |
1993-01-07 |
Basf Ag |
Thermoplastische formmassen auf der basis von polycarbonaten, styrol/acrylnitril-polymerisaten und polyolefinen
|
JPH06509576A
(ja)
|
1991-07-29 |
1994-10-27 |
ワーナー−ランバート・コンパニー |
アセチルコリンエステラーゼ阻害剤としてのキナゾリン誘導体
|
TW226375B
(da)
|
1991-10-24 |
1994-07-11 |
American Home Prod |
|
EP0672054A4
(en)
|
1991-12-19 |
1996-02-07 |
Garvan Inst Med Res |
NEW MOLECULE INHIBITING THE BIOLOGICAL FUNCTION OF THE TYROSINE NEUROPEPTIDE.
|
JPH05301826A
(ja)
|
1991-12-24 |
1993-11-16 |
Snow Brand Milk Prod Co Ltd |
プロリルエンドペプチダーゼ阻害剤
|
JPH05201970A
(ja)
|
1992-01-24 |
1993-08-10 |
Japan Tobacco Inc |
新規プロリン誘導体
|
JP3318622B2
(ja)
|
1992-05-27 |
2002-08-26 |
独立行政法人産業技術総合研究所 |
プロリルエンドペプチダーゼ阻害剤
|
GB9212308D0
(en)
|
1992-06-10 |
1992-07-22 |
Ici Plc |
Therapeutic compositions
|
GB9213215D0
(en)
|
1992-06-20 |
1992-08-05 |
Wellcome Found |
Peptides
|
JPH06116284A
(ja)
|
1992-10-02 |
1994-04-26 |
Yamanouchi Pharmaceut Co Ltd |
新規ペプチド
|
ES2149213T3
(es)
|
1992-10-05 |
2000-11-01 |
Ube Industries |
Compuesto de pirimidina.
|
US5260286A
(en)
|
1992-10-16 |
1993-11-09 |
Japan Tobacco, Inc. |
2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
|
WO1994012474A1
(en)
|
1992-11-20 |
1994-06-09 |
Japan Tobacco Inc. |
Compound with prolyl endopeptidase inhibitor activity and pharmaceutical use thereof
|
US5354758A
(en)
|
1992-12-16 |
1994-10-11 |
Japan Tobacco Inc. |
Benzomorphans useful as NMDA receptor antagonists
|
JPH06192298A
(ja)
|
1992-12-24 |
1994-07-12 |
Mitsui Toatsu Chem Inc |
新規機能性ペプチド
|
DE4326465A1
(de)
|
1993-01-20 |
1995-02-09 |
Thomae Gmbh Dr K |
Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US5750349A
(en)
|
1993-01-25 |
1998-05-12 |
Takeda Chemical Industries Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
JPH06234693A
(ja)
|
1993-02-09 |
1994-08-23 |
Snow Brand Milk Prod Co Ltd |
新規イソテトラセノン系物質及びその製造法
|
FR2701480B1
(fr)
|
1993-02-15 |
1995-05-24 |
Sanofi Elf |
Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant.
|
EP0611769A1
(en)
|
1993-02-16 |
1994-08-24 |
Merrell Dow Pharmaceuticals Inc. |
Silylated acetylcholinesterase inhibitors
|
AU4982293A
(en)
|
1993-03-02 |
1994-09-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel heterocyclic compound
|
FR2702150B1
(fr)
|
1993-03-03 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
|
FR2703050B1
(fr)
|
1993-03-24 |
1995-04-28 |
Adir |
Nouveaux dérivés bicycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
|
EP0627400A1
(en)
|
1993-06-04 |
1994-12-07 |
Merrell Dow Pharmaceuticals Inc. |
Aromatic acetylcholinesterase inhibitors
|
EP0707490A1
(en)
|
1993-06-18 |
1996-04-24 |
University Of Cincinnati |
Neuropeptide y antagonists and agonists
|
AU6983894A
(en)
|
1993-06-30 |
1995-01-24 |
Zeria Pharmaceutical Co., Ltd. |
Thiazolidine derivative and medicine containing the same
|
FR2707645B1
(fr)
|
1993-07-16 |
1995-08-11 |
Rhone Poulenc Rorer Sa |
Dérivés d'imidazo[1,2-a]pirazine-4-one, leur préparation et les médicaments les contenant.
|
FR2707643B1
(fr)
|
1993-07-16 |
1995-08-11 |
Rhone Poulenc Rorer Sa |
Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
|
US5756763A
(en)
|
1993-07-23 |
1998-05-26 |
Zaidan Hojin Biseibutsu Kagaku Kenkyukai |
Pyrrolidine derivatives
|
FR2711993B1
(fr)
|
1993-11-05 |
1995-12-01 |
Rhone Poulenc Rorer Sa |
Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
|
DE69431359T2
(de)
|
1993-12-02 |
2003-07-31 |
Merrell Pharma Inc |
Prolyl-endopeptidaseinhibitoren
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
FR2717805B1
(fr)
|
1994-03-28 |
1996-05-10 |
Rhone Poulenc Rorer Sa |
Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
|
FR2717811B1
(fr)
|
1994-03-28 |
1996-04-26 |
Rhone Poulenc Rorer Sa |
Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
|
FR2717812B1
(fr)
|
1994-03-28 |
1996-05-10 |
Rhone Poulenc Rorer Sa |
Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
|
FR2717813B1
(fr)
|
1994-03-28 |
1996-05-10 |
Rhone Poulenc Rorer Sa |
Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
|
JPH07267988A
(ja)
|
1994-03-31 |
1995-10-17 |
Yamanouchi Pharmaceut Co Ltd |
新規ペプチド
|
GB9410320D0
(en)
|
1994-05-24 |
1994-07-13 |
Fisons Corp |
Novel therapeutic method
|
GB9418443D0
(en)
|
1994-09-13 |
1994-11-02 |
Pfizer Ltd |
Therapeutic agents
|
US5663192A
(en)
|
1994-10-20 |
1997-09-02 |
Eli Lilly And Company |
Heterocyclic neuropeptide Y receptor antagonists
|
AU3953795A
(en)
|
1994-10-20 |
1996-05-15 |
Eli Lilly And Company |
Bicyclic neuropeptide y receptor antagonists
|
US6562862B1
(en)
|
1994-10-20 |
2003-05-13 |
Eli Lilly And Company |
Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
|
FR2726275B1
(fr)
|
1994-11-02 |
1996-12-06 |
Rhone Poulenc Rorer Sa |
Spiro heterocycle-imidazo(1,2-a)indeno(1,2-e)pyrazine)-4'- ones, leur preparation et les medicaments les contenants
|
IL116584A0
(en)
|
1994-12-29 |
1996-03-31 |
Res Dev Foundation |
Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
|
US5691368A
(en)
|
1995-01-11 |
1997-11-25 |
Hoechst Marion Roussel, Inc. |
Substituted oxazolidine calpain and/or cathepsin B inhibitors
|
GB9500601D0
(en)
|
1995-01-12 |
1995-03-01 |
Wellcome Found |
Modified peptides
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
US5552411A
(en)
|
1995-05-26 |
1996-09-03 |
Warner-Lambert Company |
Sulfonylquinolines as central nervous system and cardiovascular agents
|
US5668151A
(en)
|
1995-06-07 |
1997-09-16 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: piperidine derivatives
|
US5635503A
(en)
|
1995-06-07 |
1997-06-03 |
Bristol-Myers Squibb Company |
Dihydropyridine npy antagonists: piperazine derivatives
|
IL117997A0
(en)
|
1995-06-07 |
1996-10-31 |
Pfizer |
Neuropeptide Y1 specific ligands
|
US5554621A
(en)
|
1995-06-07 |
1996-09-10 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
|
JP3727383B2
(ja)
|
1995-07-31 |
2005-12-14 |
月桂冠株式会社 |
プロリルエンドペプチダーゼ阻害剤
|
PL320010A1
(en)
|
1995-09-01 |
1997-09-01 |
Lilly Co Eli |
Indolyllic antagonists of neuropeptide y receptors
|
AU6966696A
(en)
|
1995-10-05 |
1997-04-28 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
DE19544685A1
(de)
|
1995-11-30 |
1997-06-05 |
Thomae Gmbh Dr K |
Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
DE19544687A1
(de)
|
1995-11-30 |
1997-06-05 |
Thomae Gmbh Dr K |
Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
DE19544686A1
(de)
|
1995-11-30 |
1997-06-05 |
Thomae Gmbh Dr K |
Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
WO1997020820A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl compounds
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
AU7692696A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Heteroaryl derivatives
|
AU7692896A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Quinazolin-2,4-diazirines as NPY receptor antagonist
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
JPH09157253A
(ja)
|
1995-12-12 |
1997-06-17 |
Yamanouchi Pharmaceut Co Ltd |
新規アミノ酸誘導体
|
ZA9610736B
(en)
|
1995-12-22 |
1997-06-27 |
Warner Lambert Co |
2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
|
ZA9610745B
(en)
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
|
ZA9610741B
(en)
|
1995-12-22 |
1997-06-24 |
Warner Lambert Co |
4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
|
CA2242579A1
(en)
|
1996-01-09 |
1997-07-17 |
Eli Lilly And Company |
Benzimidzolyl neuropeptide y receptor antagonists
|
GB9605027D0
(en)
|
1996-03-09 |
1996-05-08 |
Pfizer Ltd |
Quinoxalinediones
|
US5662723A
(en)
|
1996-03-22 |
1997-09-02 |
Libbey Glass Inc. |
Apparatus and method for forming a decorative pattern on glassware having an edge
|
HUP9903473A3
(en)
|
1996-04-12 |
2000-09-28 |
Hoechst Marion Roussel Inc Cin |
Isatin derivatives as acetylcholinesterase inhibitors and analgesics
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
WO1997046250A1
(en)
|
1996-06-04 |
1997-12-11 |
Synaptic Pharmaceutical Corporation |
Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
|
ATE224733T1
(de)
|
1996-07-05 |
2002-10-15 |
Wwk Trust |
Zusammensetzungen zur behandlung der peripheren neuropathie, die antidepressiven verbindungen und/oder monoamino-oxidaseinhibitoren und/oder vitamin b12 und/oder neurotransmitter-vorläufer oder induktoren enthalten
|
DK0915859T3
(da)
|
1996-07-23 |
2003-03-03 |
Neurogen Corp |
Visse substituerede benzylaminderivater; en ny klasse af Neuropeptid Y1-specifikke ligander
|
JP2000515151A
(ja)
|
1996-07-23 |
2000-11-14 |
ニューロジェン・コーポレーション |
特定の置換ベンジルアミン誘導体;新規クラスの神経ペプチド―y1特異的リガンド
|
CA2260983A1
(en)
|
1996-07-23 |
1998-01-29 |
Charles A. Blum |
Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
|
AU3967297A
(en)
|
1996-08-01 |
1998-02-25 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
WO1998006703A1
(en)
|
1996-08-14 |
1998-02-19 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as mcp-1 antagonists
|
ATE218859T1
(de)
|
1996-08-23 |
2002-06-15 |
Agouron Pharma |
Liganden des neuropeptids y
|
JP3880664B2
(ja)
|
1996-09-04 |
2007-02-14 |
月桂冠株式会社 |
プロリルエンドペプチダーゼ阻害ペプチド
|
WO1998010757A2
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
|
AU4944297A
(en)
|
1996-10-08 |
1998-05-05 |
Novartis Ag |
Modulation of apoptosis
|
FR2754709B1
(fr)
|
1996-10-23 |
1999-03-05 |
Sanofi Sa |
Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
|
US6011155A
(en)
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
AU5716898A
(en)
|
1997-01-08 |
1998-08-03 |
Warner-Lambert Company |
Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
|
US20030068316A1
(en)
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
JP2894445B2
(ja)
|
1997-02-12 |
1999-05-24 |
日本たばこ産業株式会社 |
Cetp活性阻害剤として有効な化合物
|
WO1998040102A1
(en)
|
1997-03-13 |
1998-09-17 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Cytoprotective agents comprising monoamine oxidase inhibitors
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
AU743827B2
(en)
|
1997-04-09 |
2002-02-07 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
EP0975584B1
(en)
|
1997-04-16 |
2002-09-25 |
Arqule, Inc. |
Synthesis and use of alpha-ketoamide derivatives and arrays
|
CA2289190A1
(en)
|
1997-05-07 |
1998-11-12 |
Algos Pharmaceutical Corporation |
Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
|
WO1998050075A1
(en)
|
1997-05-07 |
1998-11-12 |
Algos Pharmaceutical Corporation |
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
PL193237B1
(pl)
|
1997-06-30 |
2007-01-31 |
Merz Pharma Gmbh & Co Kgaa |
Pochodne 1-aminoalkilocykloheksanu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
|
GB9716657D0
(en)
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
GB9716879D0
(en)
|
1997-08-08 |
1997-10-15 |
Shire Int Licensing Bv |
Treatment of attention deficit disorders
|
WO1999007413A1
(en)
|
1997-08-11 |
1999-02-18 |
Algos Pharmaceutical Corporation |
Substance p inhibitors in combination with nmda-blockers for treating pain
|
SE9703376D0
(sv)
|
1997-09-18 |
1997-09-18 |
Astra Ab |
A new combination
|
SE9703414D0
(sv)
|
1997-09-23 |
1997-09-23 |
Astra Ab |
New compounds
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6803357B1
(en)
|
1998-02-02 |
2004-10-12 |
New England Medical Center Hospitals, Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
JP2002506075A
(ja)
|
1998-03-09 |
2002-02-26 |
フォンダテッヒ・ベネルクス・ナムローゼ・フェンノートシャップ |
セリンペプチダーゼ調節剤
|
US6007841A
(en)
|
1998-03-13 |
1999-12-28 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for treating pain
|
GB9805561D0
(en)
|
1998-03-16 |
1998-05-13 |
Merck Sharp & Dohme |
A combination of therapeutic agents
|
US6541208B1
(en)
|
1998-03-17 |
2003-04-01 |
University Of Maryland Biotechnology Institute |
Diagnostic method for distinguishing HIV-associated dementia from other forms of dementia
|
DE19812331A1
(de)
|
1998-03-20 |
1999-09-23 |
Merck Patent Gmbh |
Piperidinderivate
|
US6054451A
(en)
|
1998-04-21 |
2000-04-25 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for alleviating pain
|
AU3879899A
(en)
|
1998-05-04 |
1999-11-23 |
Neotherapeutics, Inc. |
Novel dopamine-like 9-substituted hypoxanthine and methods of use
|
WO1999057120A1
(en)
|
1998-05-04 |
1999-11-11 |
Neotherapeutics, Inc. |
Novel serotonin-like 9-substituted hypoxanthine and methods of use
|
CN1344275A
(zh)
|
1998-05-21 |
2002-04-10 |
田纳西州立大学研究股份有限公司 |
用淀粉样蛋白抗体除去淀粉样蛋白的方法
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
PE20000728A1
(es)
|
1998-06-26 |
2000-08-21 |
Cocensys Inc |
Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
|
US6262081B1
(en)
|
1998-07-10 |
2001-07-17 |
Dupont Pharmaceuticals Company |
Composition for and method of treating neurological disorders
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
AU5027299A
(en)
|
1998-07-31 |
2000-02-28 |
Novo Nordisk A/S |
Use of glp-1 and analogues for preventing type ii diabetes
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
IL125809A
(en)
|
1998-08-17 |
2005-08-31 |
Finetech Lab Ltd |
Process and intermediates for production of donepezil and related compounds
|
IT1304904B1
(it)
|
1998-09-11 |
2001-04-05 |
Eisai Co Ltd |
Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
|
SK4592001A3
(en)
|
1998-10-16 |
2001-12-03 |
Janssen Pharmaceutica Nv |
Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition
|
CA2351224A1
(en)
|
1998-11-12 |
2000-05-25 |
Algos Pharmaceutical Corporation |
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
CA2351347A1
(en)
|
1998-11-23 |
2000-06-02 |
Bonnie Davis |
Dosage formulations for acetylcholinesterase inhibitors
|
WO2000030674A1
(en)
|
1998-11-26 |
2000-06-02 |
Ferring Bv |
Neuropeptide y y4 agents in the treatment of reproductive disorders
|
JP2002531502A
(ja)
|
1998-12-11 |
2002-09-24 |
デイビス、ボニー |
視床下部−下垂体−生殖腺軸変調に於けるアセチルコリンエステラーゼ阻害剤の使用
|
GB9902452D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902461D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
WO2000056711A1
(en)
|
1999-03-23 |
2000-09-28 |
Sumitomo Pharmaceuticals Co., Ltd. |
Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
|
CA2363984A1
(en)
|
1999-04-15 |
2000-10-26 |
Merck Frosst Canada & Co. |
Antibodies that recognize app cleaved by caspases and methods of use
|
US6121311A
(en)
|
1999-04-28 |
2000-09-19 |
Japan Tobacco Inc. |
Method for treating cocainism
|
MXPA01011321A
(es)
|
1999-05-05 |
2003-08-01 |
Johnson & Johnson |
Neuropeptidos y ligandos de receptores 3a, 4, 5, 9b-tetrahidro-1h-benz(e)indol-2-il amino derivados utiles en el tratamiento de obesidad y otros trastornos.
|
JP3148739B2
(ja)
|
1999-05-19 |
2001-03-26 |
ドーマー株式会社 |
プロリルエンドペプチダーゼ阻害剤
|
JP5249482B2
(ja)
|
1999-06-16 |
2013-07-31 |
ボストン・バイオメデイカル・リサーチ・インステイテユート |
インビボのβ−アミロイドレベルの免疫学的制御
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US6172081B1
(en)
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
US6524616B1
(en)
|
1999-06-25 |
2003-02-25 |
Wake Forest University Health Services |
Compositions and methods for treating or preventing neurodegeneration and cognitive decline and dysfunction associated with alzheimer's disease, aging, other dementia related disorders and estrogen deficiency related conditions
|
US6316449B1
(en)
|
1999-07-08 |
2001-11-13 |
Millennium Pharmaceuticals, Inc. |
Chemokine receptor antagonists
|
DE19936521A1
(de)
|
1999-08-06 |
2001-02-15 |
Gruenenthal Gmbh |
Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate
|
DE19936719A1
(de)
|
1999-08-06 |
2001-02-15 |
Gruenenthal Gmbh |
Substituierte 1,5-Dihydropyrrol-2-on-Derivate
|
AU6766800A
(en)
|
1999-08-13 |
2001-03-13 |
Trustees Of Columbia University In The City Of New York, The |
Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
|
EP1078632A1
(en)
|
1999-08-16 |
2001-02-28 |
Sanofi-Synthelabo |
Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
TWI292316B
(en)
|
1999-10-11 |
2008-01-11 |
Sod Conseils Rech Applic |
Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
|
UA72558C2
(uk)
|
1999-11-01 |
2005-03-15 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
1-аміноалкілциклогексанові антагоністи рецептора nmda
|
AU1916401A
(en)
|
1999-11-12 |
2001-06-06 |
Guilford Pharmaceuticals Inc. |
Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
EP1254108A1
(en)
|
2000-01-24 |
2002-11-06 |
MERCK SHARP & DOHME LTD. |
Gamma-secretase inhibitors
|
JP2003520849A
(ja)
|
2000-01-24 |
2003-07-08 |
ノボ ノルディスク アクティーゼルスカブ |
酵素dpp−ivの阻害剤であるn−置換2−シアノピロールおよび−ピロリン
|
MXPA02007449A
(es)
|
2000-02-03 |
2003-04-14 |
Millennium Pharm Inc |
Anticuerpos anti-ccr2 humanizados y metodos para el uso de los mismos.
|
SI1481992T1
(sl)
|
2000-02-24 |
2017-01-31 |
Washington University St. Louis |
Humanizirana protitelesa, ki vežejo amiloidni peptid beta
|
GB0005251D0
(en)
|
2000-03-03 |
2000-04-26 |
Merck Sharp & Dohme |
Therapeutic compounds
|
WO2001066096A2
(en)
|
2000-03-06 |
2001-09-13 |
Immune Network Ltd. |
Compositions for prevention and treatment of dementia
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
DE60124080T2
(de)
|
2000-03-23 |
2007-03-01 |
Elan Pharmaceuticals, Inc., San Francisco |
Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
GB0008710D0
(en)
|
2000-04-07 |
2000-05-31 |
Merck Sharp & Dohme |
Therapeutic compounds
|
WO2001078728A1
(fr)
|
2000-04-13 |
2001-10-25 |
Eisai Co., Ltd. |
Inhibiteurs d'acetylcholinesterases contenant des sels de 1-benzyl-pyridinium
|
AU2001255620A1
(en)
|
2000-04-26 |
2001-11-07 |
Warner-Lambert Company |
Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
US20010036949A1
(en)
|
2000-05-09 |
2001-11-01 |
Coe Jotham Wadsworth |
Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
|
BR0111279A
(pt)
|
2000-06-01 |
2003-11-04 |
Warner Lambert Co |
Derivados da ciclohexilamina como antagonistas para o receptor do nmda seletivo ao subtipo
|
WO2001094321A1
(en)
|
2000-06-06 |
2001-12-13 |
Warner-Lambert Company |
Bicyclic cyclohexylamines and their use as nmda receptor antagonists
|
HUP0301628A3
(en)
|
2000-06-22 |
2007-05-29 |
Pharmos Corp |
Novel non-psychotropic cannabinoids
|
GB0015488D0
(en)
|
2000-06-23 |
2000-08-16 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6713276B2
(en)
|
2000-06-28 |
2004-03-30 |
Scios, Inc. |
Modulation of Aβ levels by β-secretase BACE2
|
US6686449B2
(en)
|
2000-06-30 |
2004-02-03 |
Pharmacia & Upjohn Company |
Mutant presenilin 1 polypeptides
|
JP2004502664A
(ja)
|
2000-06-30 |
2004-01-29 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
アルツハイマー病処置用化合物
|
HUP0301622A3
(en)
|
2000-07-04 |
2006-05-29 |
Novo Nordisk As |
Purine derivatives inhibiting the enzyme dipeptidyl petidase iv (dpp-iv) and pharmaceutical compositions containing them
|
GB0016681D0
(en)
|
2000-07-06 |
2000-08-23 |
Merck Sharp & Dohme |
Therapeutic compounds
|
US6556971B1
(en)
|
2000-09-01 |
2003-04-29 |
Snap-On Technologies, Inc. |
Computer-implemented speech recognition system training
|
AU2001293056A1
(en)
|
2000-09-25 |
2002-04-08 |
Motorwiz, Inc. |
Model-based machine diagnostics and prognostics using theory of noise and communications
|
US20020151591A1
(en)
|
2000-10-17 |
2002-10-17 |
Anabella Villalobos |
Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
|
HU227197B1
(en)
|
2000-10-24 |
2010-10-28 |
Richter Gedeon Nyrt |
Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
|
US7138400B2
(en)
|
2000-11-02 |
2006-11-21 |
Merck Sharp & Dohme Limited |
Sulfamides as gamma-secretase inhibitors
|
AU2002239765A1
(en)
|
2000-11-03 |
2002-06-03 |
Proteotech, Inc. |
Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6495335B2
(en)
|
2000-12-07 |
2002-12-17 |
Mario Chojkier |
Compositions and methods for diagnosing alzheimer's disease
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
TWI245761B
(en)
|
2001-03-01 |
2005-12-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
AU2002250256B2
(en)
|
2001-03-08 |
2008-04-03 |
Emory University |
pH-dependent NMDA receptor antagonists
|
US6649196B2
(en)
|
2001-03-12 |
2003-11-18 |
Mayo Foundation For Medical Education And Research |
Methods of reducing β-amyloid polypeptides
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
TWI236474B
(en)
|
2001-04-03 |
2005-07-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
US7318923B2
(en)
|
2001-04-30 |
2008-01-15 |
Eli Lilly And Company |
Humanized anti-βantibodies
|
WO2002088307A2
(en)
|
2001-04-30 |
2002-11-07 |
Eli Lilly And Company |
Humanized antibodies
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
SI20922A
(sl)
|
2001-05-18 |
2002-12-31 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Monoklonsko protitelo, ki nevtralizira aktivnost katepsina B, in njegove uporabe
|
US6562783B2
(en)
|
2001-05-30 |
2003-05-13 |
Neurologic, Inc. |
Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitors
|
ATE396174T1
(de)
|
2001-06-01 |
2008-06-15 |
Elan Pharm Inc |
Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
|
EP1406622B1
(en)
|
2001-06-20 |
2006-02-22 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
CA2450579A1
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
CA2424645A1
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
New use of dipeptidyl peptidase iv inhibitors
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
US7183290B2
(en)
|
2001-06-27 |
2007-02-27 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
EP1399469A2
(en)
|
2001-06-27 |
2004-03-24 |
Probiodrug AG |
Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
|
WO2003002530A2
(en)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Pyrrolidines as dipeptidyl peptidase inhibitors
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
US6982264B2
(en)
|
2001-06-27 |
2006-01-03 |
Elan Pharmaceuticals, Inc. |
Substituted alcohols useful in treatment of Alzheimer's disease
|
CN1990468A
(zh)
|
2001-06-27 |
2007-07-04 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
ATE388951T1
(de)
|
2001-07-03 |
2008-03-15 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
EP1409477B1
(en)
|
2001-07-24 |
2008-09-17 |
Richter Gedeon NYRT |
Piperidine derivatives as nmda receptor antagonists
|
WO2003012141A1
(en)
|
2001-07-31 |
2003-02-13 |
Takeda Chemical Industries, Ltd. |
Method of screening alzheimer’s disease-associated gene
|
EP1420032B2
(en)
|
2001-08-03 |
2015-12-16 |
Medical & Biological Laboratories Co., Ltd. |
Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody
|
US6683091B2
(en)
|
2001-08-03 |
2004-01-27 |
Schering Corporation |
Gamma Secretase inhibitors
|
CN1780621A
(zh)
|
2001-08-03 |
2006-05-31 |
先灵公司 |
作为γ分泌酶抑制剂的磺酰胺衍生物
|
EP1519740A4
(en)
|
2001-08-17 |
2005-11-09 |
Lilly Co Eli |
FASTER IMPROVEMENT OF COGNITION IN DISEASES ASSOCIATED WITH A-BETA
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
JP2005502680A
(ja)
|
2001-08-30 |
2005-01-27 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
抗痙攣剤およびアセチルコリンエステラーゼ阻害剤による痴呆および記憶障害の処置
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
AU2002331311A1
(en)
|
2001-09-19 |
2003-04-01 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
AU2002359301B2
(en)
|
2001-10-23 |
2008-07-03 |
Comentis, Inc. |
Beta-secretase inhibitors and methods of use
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
GB0125445D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
WO2003037376A1
(fr)
|
2001-11-02 |
2003-05-08 |
Kensuke Egashira |
Prophylactiques et/ou remedes pour le traitement de l'arteriosclerose apres transplantation dans le cas de rejet de greffe
|
US7060270B2
(en)
|
2001-11-02 |
2006-06-13 |
Diagenics International Corporation |
Methods and compositions of monoclonal antibodies specific for beta-amyloid proteins
|
WO2003040183A2
(en)
|
2001-11-09 |
2003-05-15 |
The Genetics Company, Inc |
Compounds for the diagnosis/prevention/treatment of alzheimer's disease
|
EP1448200A2
(en)
|
2001-11-19 |
2004-08-25 |
Elan Pharmaceuticals, Inc. |
(4-phenyl)piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
|
EP1572894B1
(en)
|
2001-11-21 |
2016-04-13 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
|
EP1469873A4
(en)
|
2001-11-26 |
2007-10-03 |
Tufts College |
PEPTIDOMIMETIC INHIBITORS OF POST-PROLINE CLEAVAGE ENZYMES
|
WO2003048204A1
(en)
|
2001-12-06 |
2003-06-12 |
Takeda Chemical Industries, Ltd. |
Alzheimer’s disease-associated gene and protein and use thereof
|
AU2002366355A1
(en)
|
2001-12-17 |
2003-06-30 |
New York State Office Of Mental Health |
SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
|
EP1465854A4
(en)
|
2001-12-19 |
2005-06-08 |
Atherogenics Inc |
CHALCONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES
|
WO2003055514A1
(en)
|
2001-12-21 |
2003-07-10 |
Antigenics Inc. |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
WO2003057144A2
(en)
|
2001-12-26 |
2003-07-17 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
WO2003057204A2
(en)
|
2002-01-08 |
2003-07-17 |
Nordic Bioscience A/S |
Modulation of iamt (pimt or pcmt) in immune system
|
CA2473441A1
(en)
|
2002-01-18 |
2003-07-24 |
The Genetics Company Inc. |
Beta-secretase inhibitors
|
AU2003207973A1
(en)
|
2002-01-31 |
2003-09-02 |
Tel Aviv University Future Technology Development L.P. |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
US20040171614A1
(en)
|
2002-02-06 |
2004-09-02 |
Schering-Plough Corporation |
Novel gamma secretase inhibitors
|
TW200302717A
(en)
|
2002-02-06 |
2003-08-16 |
Schering Corp |
Novel gamma secretase inhibitors
|
RU2285693C2
(ru)
|
2002-02-13 |
2006-10-20 |
Ф.Хоффманн-Ля Рош Аг |
Производные пиридина и хинолина, способ их получения, фармацевтическая композиция, применение соединений для лечения заболеваний, ассоциированных с dpp-iv
|
JP4359146B2
(ja)
|
2002-02-13 |
2009-11-04 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規なピリジン−およびピリミジン−誘導体
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
DE60316416T2
(de)
|
2002-03-25 |
2008-06-26 |
Merck & Co., Inc. |
Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
|
ES2297141T3
(es)
|
2002-03-29 |
2008-05-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Derivados de (1-indanona)-(1,2,3,6-tetrahidropiridina).
|
US20070134247A9
(en)
|
2002-04-12 |
2007-06-14 |
Ramot At Tel Aviv University Ltd. |
Prevention of brain inflammation as a result of induced autoimmune response
|
PL209696B1
(pl)
|
2002-04-19 |
2011-10-31 |
Univ Toronto |
Peptyd, kompozycja peptydowa, kompozycja immunogenna, zastosowania kompozycji immunogennej oraz sposób określania czy związek stanowi inhbitor odkładania się i tworzenia włókienek amyloidu
|
ATE448242T1
(de)
|
2002-04-24 |
2009-11-15 |
Hiroshi Mori |
Gamma-sekretase-inhibitoren
|
ATE413388T1
(de)
|
2002-04-26 |
2008-11-15 |
Schering Corp |
Muskarin antagonisten
|
US7205336B2
(en)
|
2002-05-17 |
2007-04-17 |
Merck & Co., Inc. |
β-secretase inhibitors
|
ES2314200T3
(es)
|
2002-05-31 |
2009-03-16 |
H. Lundbeck A/S |
Una combinacion de un antagonista de nmda e inhibidores de esterasa de acetilcolina par ael tratamiento de la enfermedad de alzheimer.
|
BR0311608A
(pt)
|
2002-06-04 |
2005-02-22 |
Pfizer Prod Inc |
Amidas cìclicas fluoradas como inibidores da dipeptidil-peptidase iv
|
WO2003101449A2
(en)
|
2002-06-04 |
2003-12-11 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
BR0311697A
(pt)
|
2002-06-06 |
2005-03-22 |
Eisai Co Ltd |
Novos derivados condensados de imidazol
|
CN100369991C
(zh)
|
2002-06-19 |
2008-02-20 |
舒飞士特种化工有限公司 |
半光粉末涂料组合物
|
AU2003248259A1
(en)
|
2002-07-10 |
2004-02-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel azetidine derivative or salt thereof
|
DE60330485D1
(de)
|
2002-07-15 |
2010-01-21 |
Merck & Co Inc |
Zur behandlung von diabetes
|
EP1523309A2
(en)
|
2002-07-19 |
2005-04-20 |
Khalid Iqbal |
Nmda receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau
|
US7557137B2
(en)
|
2002-08-05 |
2009-07-07 |
Bristol-Myers Squibb Company |
Gamma-lactams as beta-secretase inhibitors
|
ME00396B
(me)
|
2002-08-21 |
2011-05-10 |
Boehringer Ingelheim Pharma |
8-(3-AMINO-PIPERIDIN-1-IL)-KSANTINI, NJIHOVO DOBIJANJE l NJIHOVA PRIMJENA KAO FARMACEUTSKIH KOMPOZICIJA
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
WO2010012004A2
(en)
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of California |
Monoclonal antibodies specific for pathological amyoid aggregates common to amyloids formed from proteins of differing sequence
|
EP1578361B1
(en)
|
2002-09-12 |
2011-04-20 |
The Regents of The University of California |
Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
|
WO2004024921A1
(ja)
|
2002-09-12 |
2004-03-25 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
ヒト抗ヒトmcp−1抗体及び該抗体フラグメント
|
ES2201929B1
(es)
|
2002-09-12 |
2005-05-16 |
Araclon Biotech, S.L. |
Anticuerpos policlonales, metodo de preparacion y uso de los mismos.
|
WO2005025516A2
(en)
|
2003-09-12 |
2005-03-24 |
The Regents Of The University Of California |
Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates
|
WO2010011999A2
(en)
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of California |
Methods and compositions for eliciting an amyloid-selective immune response
|
WO2004026822A2
(en)
|
2002-09-19 |
2004-04-01 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
US20050282871A1
(en)
|
2002-09-20 |
2005-12-22 |
Burrill Ii Leland C |
3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
WO2004029629A1
(en)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
|
WO2004031400A2
(en)
|
2002-10-01 |
2004-04-15 |
Northwestern University |
Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof
|
GB0223039D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
GB0223038D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
WO2004032836A2
(en)
|
2002-10-07 |
2004-04-22 |
Merck & Co., Inc. |
Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors
|
WO2004033455A2
(en)
|
2002-10-08 |
2004-04-22 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
GB0223494D0
(en)
|
2002-10-09 |
2002-11-13 |
Neuropharma Sa |
Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
|
AU2003279216A1
(en)
|
2002-10-09 |
2004-05-04 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
RU2301803C2
(ru)
|
2002-10-18 |
2007-06-27 |
Мерк Энд Ко., Инк. |
Производные гексагидродиазепинона, фармацевтическая композиция, их содержащая, и применение для получения лекарственного средства для лечения инсулиннезависимого диабета
|
CN100339070C
(zh)
|
2002-10-24 |
2007-09-26 |
莫茨药物股份两合公司 |
包含1-氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
|
US20040082543A1
(en)
|
2002-10-29 |
2004-04-29 |
Pharmacia Corporation |
Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
|
AU2003286776A1
(en)
|
2002-10-30 |
2004-06-07 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
WO2004039773A2
(en)
|
2002-10-30 |
2004-05-13 |
Nordic Bioscience A/S |
Coumpounds modulating the activity of gapdh and/or iamt
|
GB0225474D0
(en)
|
2002-11-01 |
2002-12-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
FR2846667B1
(fr)
|
2002-11-06 |
2004-12-31 |
Pasteur Institut |
Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
|
AU2003290577B2
(en)
|
2002-11-07 |
2008-12-11 |
Merck Sharp & Dohme Corp. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP4494212B2
(ja)
|
2002-11-12 |
2010-06-30 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アルツハイマー病の治療用フェニルカルボキサミドベータセクレターゼ阻害剤
|
AU2002952946A0
(en)
|
2002-11-27 |
2002-12-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
WO2004050022A2
(en)
|
2002-12-04 |
2004-06-17 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US7420079B2
(en)
|
2002-12-09 |
2008-09-02 |
Bristol-Myers Squibb Company |
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
|
AU2003303239A1
(en)
|
2002-12-19 |
2004-07-14 |
Atherogenics, Inc. |
Process of making chalcone derivatives
|
AU2003297219A1
(en)
|
2002-12-20 |
2004-07-22 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US7371853B2
(en)
|
2003-01-07 |
2008-05-13 |
Merck & Co., Inc. |
Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's disease
|
EP1589969A4
(en)
|
2003-01-17 |
2008-08-13 |
Merck & Co Inc |
3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
US7388019B2
(en)
|
2003-01-31 |
2008-06-17 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US20060188512A1
(en)
|
2003-02-01 |
2006-08-24 |
Ted Yednock |
Active immunization to generate antibodies to solble a-beta
|
KR100810810B1
(ko)
|
2003-02-04 |
2008-03-06 |
에프. 호프만-라 로슈 아게 |
감마-세크레타제 억제제로서 말론아마이드 유도체
|
ES2344645T3
(es)
|
2003-02-10 |
2010-09-02 |
Applied Molecular Evolution, Inc. |
Moleculas de union al abeta.
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
US20040229816A1
(en)
|
2003-02-18 |
2004-11-18 |
Daniel Paris |
Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
AU2003207881A1
(en)
|
2003-02-28 |
2004-09-17 |
Aic |
Dipeptidyl peptidase inhibitors
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
EP1454627A1
(en)
|
2003-03-06 |
2004-09-08 |
MyoContract Ltd. |
Alpha-Keto carbonyl calpain inhibitors
|
WO2004084830A2
(en)
|
2003-03-21 |
2004-10-07 |
Buck Institute |
Method for treating alzheimer’s dementia
|
US20040191334A1
(en)
|
2003-03-24 |
2004-09-30 |
Pang-Chui Shaw |
Use of transhinone derivates as cholinesterase inhibitors in treating related diseases
|
US20040242568A1
(en)
|
2003-03-25 |
2004-12-02 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
KR20060054174A
(ko)
|
2003-03-28 |
2006-05-22 |
센토코 인코포레이티드 |
항-아밀로이드 항체, 조성물, 방법 및 용도
|
RU2358735C2
(ru)
|
2003-03-28 |
2009-06-20 |
Акадиа Фармасьютикалз Инк. |
Агонисты м1 мускариновых рецепторов для противоболевой терапии
|
MXPA05010760A
(es)
|
2003-04-09 |
2005-12-12 |
Wyeth Corp |
Derivados de acido 2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)alquil fosfonico y su uso como antagonistas de receptor de n-metil-d-aspartato (nmda).
|
GB0308382D0
(en)
|
2003-04-10 |
2003-05-21 |
Univ Cambridge Tech |
Therapeutic methods and means
|
GB0308318D0
(en)
|
2003-04-10 |
2003-05-14 |
Merck Sharp & Dohme |
Therapeutic agents
|
WO2004089362A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
2-cyanopyrroles and their analogues as ddp-iv inhibitors
|
EP1622870A2
(en)
|
2003-05-05 |
2006-02-08 |
Prosidion Ltd. |
Glutaminyl based dp iv-inhibitors
|
EP1620091B1
(en)
|
2003-05-05 |
2010-03-31 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
CA2524009C
(en)
|
2003-05-05 |
2014-04-29 |
Probiodrug Ag |
Use of effectors of glutaminyl and glutamate cyclases
|
ES2246105B1
(es)
|
2003-05-08 |
2007-03-01 |
Araclon Biotech, S.L. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
CA2525124A1
(en)
|
2003-05-13 |
2004-11-25 |
Schering Corporation |
Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
|
CN1787823A
(zh)
|
2003-05-14 |
2006-06-14 |
麦克公司 |
作为二肽基肽酶抑制剂用于治疗或预防糖尿病的3-氨基-4-苯基丁酸衍生物
|
EP1625122A1
(en)
|
2003-05-14 |
2006-02-15 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
JP4818114B2
(ja)
|
2003-05-16 |
2011-11-16 |
メルク シャープ エンド ドーム リミテッド |
γ−セクレターゼ阻害剤としてのシクロヘキシルスルホン類
|
MXPA05012493A
(es)
|
2003-05-27 |
2006-05-25 |
Forest Laboratories |
Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
JP2006527194A
(ja)
|
2003-06-06 |
2006-11-30 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼ阻害剤としての縮合インドール
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
AU2004249163A1
(en)
|
2003-06-17 |
2004-12-29 |
Merck & Co., Inc. |
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
CN101090901B
(zh)
|
2003-06-20 |
2010-12-15 |
霍夫曼-拉罗奇有限公司 |
作为dpp-iv抑制剂的六氢吡啶并异喹啉类
|
DE602004030244D1
(de)
|
2003-06-20 |
2011-01-05 |
Hoffmann La Roche |
Itoren
|
WO2005004802A2
(en)
|
2003-06-30 |
2005-01-20 |
Merck & Co., Inc. |
N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
|
EP2719394B1
(en)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides for treating amyloid-associated diseases
|
AU2004255191A1
(en)
|
2003-07-01 |
2005-01-20 |
Merck & Co., Inc. |
Phenylcarboxylate beta-secretase inhibitors for the treatment of Alzheimer's disease
|
WO2005007614A1
(en)
|
2003-07-03 |
2005-01-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services 6011 |
Monoamine oxidase inhibitors
|
AU2004257367A1
(en)
|
2003-07-16 |
2005-01-27 |
Resverlogix, Inc. |
Compounds and methods for downregulating the effects of TGF-beta
|
EP1671129A1
(en)
|
2003-07-21 |
2006-06-21 |
Angiogenetics Sweden AB |
Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway
|
WO2005014041A2
(en)
|
2003-07-24 |
2005-02-17 |
Novartis Ag |
Use of an amyloid beta dna vaccine for the treatment and/or prevention of amyloid diseases
|
AU2004258751C1
(en)
|
2003-07-28 |
2008-07-17 |
Merz Pharma Gmbh & Co. Kgaa |
The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
|
US7259160B2
(en)
|
2003-07-31 |
2007-08-21 |
Merck & Co., Inc. |
Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
US20050124016A1
(en)
|
2003-08-01 |
2005-06-09 |
Enh Research Institute |
Antibodies specific for toxic amyloid beta protein oligomers
|
GB0318447D0
(en)
|
2003-08-05 |
2003-09-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
BRPI0413452A
(pt)
|
2003-08-13 |
2006-10-17 |
Takeda Pharmaceutical |
composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv
|
CN1835936A
(zh)
|
2003-08-14 |
2006-09-20 |
默克公司 |
用于治疗阿尔茨海默氏病的大环β-分泌酶抑制剂
|
WO2005018424A2
(en)
|
2003-08-18 |
2005-03-03 |
Research Foundation For Mental Hygiene, Inc. |
Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
AU2003298171A1
(en)
|
2003-09-05 |
2005-03-29 |
Cellzome Ag |
Protein complexes associated with app-processing
|
WO2005030751A2
(en)
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2005026148A1
(en)
|
2003-09-08 |
2005-03-24 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
PE20050948A1
(es)
|
2003-09-09 |
2005-12-16 |
Japan Tobacco Inc |
Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
|
CA2538220A1
(en)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
AU2004276050B2
(en)
|
2003-09-24 |
2010-02-25 |
Merck Sharp & Dohme Limited |
Gamma-secretase inhibitors
|
ATE396973T1
(de)
|
2003-10-03 |
2008-06-15 |
Merck & Co Inc |
Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
|
CN1894217B
(zh)
|
2003-10-06 |
2011-09-21 |
弗·哈夫曼-拉罗切有限公司 |
用作γ-分泌酶抑制剂的取代的二苯并氮杂*和苯并二氮杂*
|
PL380189A3
(pl)
|
2003-10-06 |
2007-01-08 |
Torrent Pharmaceuticals Limited |
Azolidynokarbonitryle i ich zastosowanie jako inhibitory DPP-IV
|
BRPI0415109A
(pt)
|
2003-10-08 |
2006-11-28 |
Pfizer |
compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda
|
AU2004283461B2
(en)
|
2003-10-15 |
2010-02-11 |
Probiodrug Ag |
Use of effectors of glutaminyl and glutamate cyclases
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
ATE519486T1
(de)
|
2003-10-16 |
2011-08-15 |
Neurosearch As |
Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
EP1682109B1
(en)
|
2003-10-22 |
2008-10-15 |
Merz Pharma GmbH & Co. KGaA |
The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic as peptides in amyloidopathies
|
EP1824846A2
(en)
|
2003-11-03 |
2007-08-29 |
Probiodrug AG |
Novel compounds for the treatment of neurological disorders
|
AU2004286857A1
(en)
|
2003-11-04 |
2005-05-19 |
Merck & Co., Inc. |
Fused phenylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
ES2298837T3
(es)
|
2003-11-11 |
2008-05-16 |
F. Hoffmann-La Roche Ag |
Derivados del acido fosfinico, inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer.
|
KR20070054762A
(ko)
|
2003-11-12 |
2007-05-29 |
페노믹스 코포레이션 |
헤테로시클릭 보론산 화합물
|
US7354942B2
(en)
|
2003-11-24 |
2008-04-08 |
Merck & Co., Inc. |
Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
UY28650A1
(es)
|
2003-12-05 |
2005-02-28 |
Forest Laboratories |
Memantina para la prevencion o disminucion de la conducta suicida y para el tratamiento de la depresion mayor asociada con esta conducta
|
EP1541143A1
(en)
|
2003-12-09 |
2005-06-15 |
Graffinity Pharmaceuticals Aktiengesellschaft |
Dpp-iv inhibitors
|
EP1541148A1
(en)
|
2003-12-09 |
2005-06-15 |
Graffinity Pharmaceuticals Aktiengesellschaft |
Dpp-iv inhibitors
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
CA2548849A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
|
CA2554617A1
(en)
|
2004-01-22 |
2005-08-04 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
|
CA2554959A1
(en)
|
2004-01-29 |
2005-08-11 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
US7304086B2
(en)
|
2004-02-05 |
2007-12-04 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
AU2005215775B2
(en)
|
2004-02-13 |
2011-02-03 |
Neuromolecular, Inc. |
Combination of a NMDA receptor antagonist and an anti-depressive drug MAO-inhibitor or a GADPH-inhibitor for the treatment of psychiatric conditions
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
DK1758905T3
(da)
|
2004-02-18 |
2009-08-24 |
Boehringer Ingelheim Int |
8-[3-amino-piperidin-1-yl]-xanthiner, deres fremstilling og deres anvendelse som DPP-IV-hæmmer
|
US7807157B2
(en)
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
BRPI0507972A
(pt)
|
2004-02-23 |
2007-07-24 |
Tufts College |
composto ,composição farmacêutica , uso de um composto, método para inibição da atividade proteolìtica de uma enzima de clivagem pós prolina e composição farmacêutica embalada
|
EP1593671A1
(en)
|
2004-03-05 |
2005-11-09 |
Graffinity Pharmaceuticals AG |
DPP-IV inhibitors
|
WO2005087235A1
(en)
|
2004-03-09 |
2005-09-22 |
National Health Research Institutes |
Pyrrolidine compounds
|
CN102134231B
(zh)
|
2004-03-15 |
2020-08-04 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
JP2007529556A
(ja)
|
2004-03-19 |
2007-10-25 |
アクソニクス インコーポレイテッド |
認知障害の処置に有用なアセチルコリンエステラーゼ阻害剤およびn−メチル−d−アスパラギン酸拮抗剤
|
WO2005095339A1
(en)
|
2004-03-31 |
2005-10-13 |
Pfizer Products Inc. |
Dicyanopyrrolidines as dipeptidyl peptidase iv inhibitors
|
WO2005097103A2
(en)
|
2004-04-01 |
2005-10-20 |
Axys Pharmaceuticals, Inc. |
Diabetes and metabolic syndrome therapy utilizing cathepsin b inhibitors
|
WO2005097768A2
(en)
|
2004-04-05 |
2005-10-20 |
Schering Corporation |
Novel gamma secretase inhibitors
|
JP2007533743A
(ja)
|
2004-04-20 |
2007-11-22 |
メルク エンド カムパニー インコーポレーテッド |
アルツハイマー病治療のためのβ−セクレターゼ阻害薬として有用な1,3,5−置換フェニル誘導体化合物
|
CA2563639A1
(en)
|
2004-04-20 |
2005-11-03 |
Merck & Co., Inc. |
2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
US9549895B2
(en)
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
JPWO2005105998A1
(ja)
|
2004-04-27 |
2008-07-31 |
財団法人化学及血清療法研究所 |
ヒト抗アミロイドβペプチド抗体およびその抗体フラグメント
|
WO2005108382A1
(en)
|
2004-05-04 |
2005-11-17 |
Merck & Co., Inc. |
1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
EP1753748B1
(en)
|
2004-05-12 |
2009-07-29 |
Pfizer Products Inc. |
Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
|
US7449599B2
(en)
|
2004-05-13 |
2008-11-11 |
Merck + Co Inc. |
Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
CN1960990A
(zh)
|
2004-05-18 |
2007-05-09 |
默克公司 |
作为用于治疗或预防糖尿病的二肽基肽酶-ⅳ抑制剂的环己基丙氨酸衍生物
|
EP1598341A1
(en)
|
2004-05-21 |
2005-11-23 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
WO2005118555A1
(en)
|
2004-06-04 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
ATE476993T1
(de)
|
2004-06-07 |
2010-08-15 |
Univ Ramot |
Verfahren zur passiven immunisierung gegen eine durch amyloidaggregation gekennzeichnete krankheit oder erkrankung mit vermindertem nervenentzündungsrisiko
|
EP1604662A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
|
EP1604980A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
EP1604989A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
AU2005257904A1
(en)
|
2004-06-15 |
2006-01-05 |
Merck Sharp & Dohme Corp. |
Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
|
GB0413389D0
(en)
|
2004-06-16 |
2004-07-21 |
Astrazeneca Ab |
Chemical compounds
|
US7482336B2
(en)
|
2004-06-21 |
2009-01-27 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
CA2572289A1
(en)
|
2004-06-30 |
2006-08-17 |
Centocor, Inc. |
Anti-mcp-1 antibodies, compositions, methods and uses
|
JP2008505100A
(ja)
|
2004-06-30 |
2008-02-21 |
シェーリング コーポレイション |
ガンマ−セクレターゼ阻害剤としての置換n−アリールスルホニル複素環アミン
|
CA2572602A1
(en)
|
2004-07-02 |
2006-02-09 |
Northwestern University |
Monolocal antibodies that target pathological assemblies of amyloid .beta. (abeta)
|
CA2573848A1
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Constrained cyano compounds
|
RU2007105346A
(ru)
|
2004-07-14 |
2008-09-27 |
Новартис АГ (CH) |
Комбинация ингибиторов dpp-iv и соединений, модулирующих 5-нт3-и/или 5-нт4-рецепторы
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
WO2006008661A2
(en)
|
2004-07-19 |
2006-01-26 |
Neurochem (International) Limited |
Diagnostic methods of multiple organ amyloidosis
|
US7955812B2
(en)
|
2004-07-19 |
2011-06-07 |
The General Hospital Corporation |
Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
|
WO2006014762A1
(en)
|
2004-07-22 |
2006-02-09 |
Schering Corporation |
Substituted amide beta secretase inhibitors
|
AR050184A1
(es)
|
2004-07-28 |
2006-10-04 |
Schering Corp |
Inhibidores macrociclicos de beta-secretasa
|
HUP0401523A3
(en)
|
2004-07-29 |
2007-05-02 |
Richter Gedeon Vegyeszet |
Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
|
TWI355389B
(en)
|
2004-07-30 |
2012-01-01 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide a
|
EP1623983A1
(en)
|
2004-08-05 |
2006-02-08 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
Heterocyclic compounds useful as DPP-IV inhibitors
|
EP1787998A4
(en)
|
2004-08-11 |
2008-08-27 |
Mitsubishi Chem Corp |
ANTIBODIES AND USE RELATING THERETO
|
CN101005877A
(zh)
|
2004-08-23 |
2007-07-25 |
默克公司 |
作为用于治疗或预防糖尿病的二肽基肽酶-ⅳ抑制剂的稠合三唑衍生物
|
WO2006021413A1
(en)
|
2004-08-25 |
2006-03-02 |
Santhera Pharmaceuticals (Schweiz) Ag |
Alpha-keto carbonyl calpain inhibitors
|
JP2008510756A
(ja)
|
2004-08-25 |
2008-04-10 |
サンセラ ファーマシューティカルズ (シュバイツ) アーゲー |
α−ケトカルボニルカルパイン阻害剤
|
US7388007B2
(en)
|
2004-08-26 |
2008-06-17 |
Bristol-Myers Squibb Company |
Gamma-lactams as beta-secretase inhibitors
|
TWI374935B
(en)
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
EP1791818A1
(en)
|
2004-09-14 |
2007-06-06 |
The Genetics Company, Inc. |
Hydrazone derivatives and their use as beta secretase inhibitors
|
US20080207527A1
(en)
|
2004-09-17 |
2008-08-28 |
Comentis, Inc. |
Bicyclic Compounds Which Inhibit Beta-Secretase Activity and Methods of Use Thereof
|
EP1799660A2
(en)
|
2004-09-17 |
2007-06-27 |
Comentis, Inc. |
Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof
|
EP1799260A4
(en)
|
2004-09-29 |
2011-09-28 |
Centocor Inc |
ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, TECHNIQUES AND USES
|
US7884104B2
(en)
|
2004-10-01 |
2011-02-08 |
Merck Sharp & Dohme Corp. |
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
WO2006042103A2
(en)
|
2004-10-05 |
2006-04-20 |
Axys Pharmaceuticals, Inc. |
Reversible inhibitors of cathepsin b
|
KR20070099527A
(ko)
|
2004-10-08 |
2007-10-09 |
노파르티스 아게 |
유기 화합물의 조합물
|
US7256866B2
(en)
|
2004-10-12 |
2007-08-14 |
Asml Netherlands B.V. |
Lithographic apparatus and device manufacturing method
|
EP2008660A1
(en)
|
2004-10-12 |
2008-12-31 |
Ernir Snorrason |
Inhibitors of acetylcholinesterase for treating skin diseases
|
EP1804794B1
(en)
|
2004-10-13 |
2013-07-31 |
Merck Sharp & Dohme Corp. |
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease
|
US20090004302A1
(en)
|
2004-10-15 |
2009-01-01 |
Biopharmacopae Design International Inc. |
Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer
|
WO2006047248A1
(en)
|
2004-10-25 |
2006-05-04 |
Novartis Ag |
Combination of dpp-iv inhibitor, ppar antidiabetic and metformin
|
JP5173426B2
(ja)
|
2004-10-25 |
2013-04-03 |
メルク・シャープ・エンド・ドーム・コーポレイション |
抗addl抗体およびこの使用
|
AU2005297854A1
(en)
|
2004-10-28 |
2006-05-04 |
Sanko Junyaku Co., Ltd. |
Method of examining Alzheimer's disease and diagnostic reagent
|
US7932275B2
(en)
|
2004-10-29 |
2011-04-26 |
Merck, Sharp & Dohme Corp. |
2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's disease
|
CA2587083A1
(en)
|
2004-11-17 |
2006-05-26 |
Merck & Co., Inc. |
Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
|
CA2587360A1
(en)
|
2004-11-23 |
2006-06-01 |
Merck & Co., Inc. |
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2006057983A1
(en)
|
2004-11-23 |
2006-06-01 |
Merck & Co., Inc. |
Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2006058059A2
(en)
|
2004-11-23 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
|
CA2588296A1
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
AU2005309606B2
(en)
|
2004-11-29 |
2011-01-06 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
EP1851216A2
(en)
|
2004-11-30 |
2007-11-07 |
F.Hoffmann-La Roche Ag |
Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
|
WO2006060473A2
(en)
|
2004-12-03 |
2006-06-08 |
Mucosal Therapeutics Llc |
Methods of treatment of injured or diseased joints with lubricin compositions
|
PE20061329A1
(es)
|
2004-12-15 |
2006-12-08 |
Neuralab Ltd |
Anticuerpos ab humanizados para mejorar la cognicion
|
ES2396555T3
(es)
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
US20060240486A1
(en)
|
2004-12-15 |
2006-10-26 |
Johnson-Wood Kelly L |
Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
|
WO2006066171A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Amyloid βετα antibodies for use in improving cognition
|
MX2007007434A
(es)
|
2004-12-20 |
2007-07-17 |
Hoffmann La Roche |
Derivados de 4-aminopiperidina.
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
JP2008524331A
(ja)
|
2004-12-21 |
2008-07-10 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
EP1827468B1
(en)
|
2004-12-23 |
2012-08-22 |
Curaxis Pharmaceutical Corporation |
Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
|
WO2006070394A1
(en)
|
2004-12-28 |
2006-07-06 |
Council Of Scientific And Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
US20080194548A1
(en)
|
2005-01-06 |
2008-08-14 |
Forrest Michael J |
Drug Combination Therapy and Pharmaceutical Compositions for Treating Inflammatory Disorders
|
AU2006206653A1
(en)
|
2005-01-19 |
2006-07-27 |
Merck & Co., Inc. |
Aminomethyl beta-secretase inhibitors for the treatment of Alzheimer's disease
|
CA2594773A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
WO2006081171A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
TW200640529A
(en)
|
2005-02-28 |
2006-12-01 |
Thomas Christian Lines |
Composition for treating mental health disorders
|
US20080194698A1
(en)
|
2005-03-07 |
2008-08-14 |
Michael Hermanussen |
Nmda Receptor Antagonists in the Medical Intervention of Metabolic Disorders
|
ES2259270B1
(es)
|
2005-03-09 |
2007-11-01 |
Consejo Superior De Investigaciones Cientificas |
Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
|
WO2006099352A1
(en)
|
2005-03-10 |
2006-09-21 |
Bristol-Myers Squibb Company |
Novel isophthalates as beta-secretase inhibitors
|
FR2883285B1
(fr)
|
2005-03-17 |
2007-05-18 |
Sanofi Aventis Sa |
Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
|
ES2318918B1
(es)
|
2005-04-01 |
2010-02-16 |
Biotherapix Molecular Medicines, S.L.U. |
Anticuerpos humanos con capacidad de union al peptido beta-amiloide y sus aplicaciones.
|
CN101166523A
(zh)
|
2005-04-27 |
2008-04-23 |
诺瓦提斯公司 |
治疗动脉粥样硬化的方法
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
TW200716174A
(en)
|
2005-05-19 |
2007-05-01 |
Centocor Inc |
Anti-MCP-1 antibodies, compositions, methods and uses
|
US7741448B2
(en)
|
2005-06-21 |
2010-06-22 |
Medical & Biological Laboratories Co., Ltd. |
Antibody having inhibitory effect on amyloid fibril formation
|
EP1910364B1
(en)
|
2005-07-18 |
2012-03-21 |
Merck Sharp & Dohme Corp. |
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2007019080A2
(en)
|
2005-08-03 |
2007-02-15 |
Merck & Co., Inc. |
Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2007019078A2
(en)
|
2005-08-03 |
2007-02-15 |
Merck & Co., Inc. |
Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
US7338974B2
(en)
|
2005-08-12 |
2008-03-04 |
Bristol-Myers Squibb Company |
Macrocyclic diaminopropanes as beta-secretase inhibitors
|
WO2007022416A2
(en)
|
2005-08-18 |
2007-02-22 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
EP1931656B1
(en)
|
2005-09-28 |
2011-02-09 |
Robert Ternansky |
Novel drugs for dementia
|
WO2007051333A1
(en)
|
2005-11-02 |
2007-05-10 |
Oncalis Ag |
Triazine beta-secretase inhibitors
|
NZ568384A
(en)
|
2005-12-12 |
2011-09-30 |
Ac Immune Sa |
Therapeutic vaccine comprising Abeta peptide
|
NO345996B1
(no)
|
2005-12-12 |
2021-12-13 |
Ac Immune Sa |
A beta 1-42-spesifikke monoklonale antistoffer med terapeutiske egenskaper.
|
RU2448964C2
(ru)
|
2006-01-20 |
2012-04-27 |
Шеринг Корпорейшн |
КАРБОЦИКЛИЧЕСКИЕ И ГЕТЕРОЦИКЛИЧЕСКИЕ АРИЛСУЛЬФОНЫ, ИХ ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, ОБЛАДАЮЩАЯ СВОЙСТВАМИ ИНГИБИТОРА γ-СЕКРЕТАЗЫ
|
WO2007097251A1
(ja)
|
2006-02-22 |
2007-08-30 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
抗アミロイドβペプチド抗体産生誘導用のペプチドワクチン
|
UA94734C2
(ru)
|
2006-03-30 |
2011-06-10 |
Глаксо Груп Лимитед |
ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
|
PL2468770T3
(pl)
|
2006-07-14 |
2018-07-31 |
Ac Immune S.A. |
Humanizowane przeciwciało przeciw amyloidowi beta
|
PL2074145T3
(pl)
|
2006-10-02 |
2017-11-30 |
Ac Immune S.A. |
Humanizowane przeciwciało przeciw amyloidowi beta
|
WO2008054698A2
(en)
|
2006-10-30 |
2008-05-08 |
Merck & Co., Inc. |
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
JP5379692B2
(ja)
|
2006-11-09 |
2013-12-25 |
プロビオドルグ エージー |
潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体
|
US7741354B2
(en)
|
2006-11-09 |
2010-06-22 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
DK2091945T3
(da)
|
2006-11-09 |
2014-04-22 |
Probiodrug Ag |
Nye inhibitorer af glutaminylcyclase
|
ATE554085T1
(de)
|
2006-11-30 |
2012-05-15 |
Probiodrug Ag |
Neue inhibitoren von glutaminylcyclase
|
US20100216875A1
(en)
|
2006-12-20 |
2010-08-26 |
Gregory Hook |
Methods of treating alzheimer's disease
|
US7803810B2
(en)
|
2007-03-09 |
2010-09-28 |
Probiodrug Ag |
Inhibitors
|
JP5675343B2
(ja)
|
2007-04-18 |
2015-02-25 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としての尿素誘導体
|
US9656991B2
(en)
|
2007-04-18 |
2017-05-23 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
US8772508B2
(en)
|
2007-04-18 |
2014-07-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
US8202897B2
(en)
|
2007-04-18 |
2012-06-19 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclases
|
ES2474693T3
(es)
|
2007-04-18 |
2014-07-09 |
Probiodrug Ag |
Derivados de ciano-guanidina como inhibidores de glutaminil ciclasa
|
ES2478673T3
(es)
|
2007-04-18 |
2014-07-22 |
Probiodrug Ag |
Derivados de tioxoquinazolinona como inhibidores de la glutaminil ciclasa
|
WO2008128984A1
(en)
|
2007-04-20 |
2008-10-30 |
Probiodrug Ag |
Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
|
CA2687765A1
(en)
|
2007-05-25 |
2008-12-04 |
Elan Pharmaceuticals, Inc. |
Pyrazolopyrrolidines as inhibitors of gamma secretase
|
KR101600095B1
(ko)
|
2007-06-12 |
2016-03-07 |
에이씨 이뮨 에스.에이. |
모노클로널 항 베타 아밀로이드 항체
|
CA2691542A1
(en)
|
2007-07-05 |
2009-01-15 |
Schering Corporation |
Tetrahydropyranochromene gamma secretase inhibitors
|
EP2178882B1
(en)
|
2007-07-17 |
2013-04-17 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
EA026787B1
(ru)
|
2007-08-27 |
2017-05-31 |
Общество С Ограниченной Ответственностью "Ниармедик Плюс" |
Конструкция нуклеиновой кислоты и ее применение для лечения, предотвращения и сдерживания болезни альцгеймера
|
US20100239570A1
(en)
|
2007-09-13 |
2010-09-23 |
Roger Nitsch |
Moncolonal amyloid beta (abeta) - specific antibody and uses thereof
|
MX2010002938A
(es)
|
2007-09-24 |
2010-04-01 |
Comentis Inc |
Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
|
GB0720912D0
(en)
|
2007-10-25 |
2007-12-05 |
Univ Cardiff |
Monoclonal Anitbody for APP
|
EP2226081A4
(en)
|
2007-10-25 |
2011-10-12 |
Univ Kagoshima |
PEPTIDE VACCINE WITH A MIMIC MOLECULE OF AMYLOID PEPTIDE
|
WO2009056490A1
(en)
|
2007-10-29 |
2009-05-07 |
Innogenetics Nv |
NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
|
MY158903A
(en)
|
2007-11-16 |
2016-11-30 |
Univ Rockefeller |
Antibodies specific for the protofibril form of beta-amyloid protein
|
EP2231180B1
(en)
|
2008-01-16 |
2016-08-17 |
Ben-gurion University Of The Negev Research And Development Authority |
Vaccine for alzheimer's disease
|
ITNA20080006A1
(it)
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
JP2011514342A
(ja)
|
2008-02-28 |
2011-05-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アルツハイマー病治療用2−アミノイミダゾールベータ−セクレターゼ阻害剤
|
CN102203124A
(zh)
|
2008-07-25 |
2011-09-28 |
雅培制药有限公司 |
淀粉状蛋白β肽类似物,其寡聚物,用于制备的方法以及包括所述类似物或寡聚物的组合物,及其用途
|
WO2010016912A2
(en)
|
2008-08-07 |
2010-02-11 |
Mercia Pharma, Llc |
Immunotherapeutic compositions for the treatment of alzheimer's disease
|
WO2010021680A2
(en)
|
2008-08-19 |
2010-02-25 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of beta-secretase
|
DK2344157T3
(da)
|
2008-09-04 |
2016-09-05 |
Probiodrug Ag |
Nye inhibitorer
|
US8512709B2
(en)
|
2008-10-16 |
2013-08-20 |
The Chemo-Sero-Therapeutic Research Institue |
Modified amyloid β peptide
|
CN102317289A
(zh)
|
2008-11-23 |
2012-01-11 |
辉瑞大药厂 |
作为β分泌酶抑制剂的内酰胺
|
US8609897B2
(en)
|
2009-02-06 |
2013-12-17 |
Merck Sharp & Dohme Corp. |
Trifluoromethylsulfonamide gamma secretase inhibitor
|
WO2010094242A1
(en)
|
2009-02-20 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
EP2475428B1
(en)
*
|
2009-09-11 |
2015-07-01 |
Probiodrug AG |
Heterocylcic derivatives as inhibitors of glutaminyl cyclase
|
JP6026284B2
(ja)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤
|
JP5688745B2
(ja)
|
2010-03-10 |
2015-03-25 |
プロビオドルグ エージー |
グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
|
US8541596B2
(en)
|
2010-04-21 |
2013-09-24 |
Probiodrug Ag |
Inhibitors
|
WO2012123563A1
(en)
|
2011-03-16 |
2012-09-20 |
Probiodrug Ag |
Benz imidazole derivatives as inhibitors of glutaminyl cyclase
|
AU2014230249B2
(en)
|
2013-03-15 |
2016-09-01 |
Vivoryon Therapeutics N.V. |
Novel inhibitors
|
CN103524486B
(zh)
*
|
2013-09-18 |
2016-03-02 |
中国科学院昆明植物研究所 |
N-喹啉基取代的β-内酰胺类化合物及其药物组合物和合成方法与应用
|